Measuring Oncological Value of Exercise and Statin

PHASE3RecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Prostate CancerBreast CancerKidney CancerOvarian CancerMetastatic Breast CancerMetastatic Kidney CancerMetastatic Renal Cell CarcinomaMetastatic Renal CancerMetastatic Prostate CancerMetastatic Prostate AdenocarcinomaMetastatic Ovarian CancerMetastatic Ovary Cancer
Interventions
BEHAVIORAL

Guided physical exercise

Patients will be participating in guided physical exercise program regularly two times / week at a sports facility and guided by a professional trainer. They will participate in aerobic and resistance exercises during the sessions.

DRUG

Atorvastatin

Patients will be participating in guided physical exercise program regularly two times / week at a sports facility and guided by a professional trainer. They will participate in aerobic and resistance exercises during the sessions. In addition to the exercise program they will be given atorvastatin 40 mg QD medication.

OTHER

Independent exercise

The control group is advised of the benefits of physical exercise and they get an exercise program to follow. Participants in the control group exercise on their own.

Trial Locations (1)

33520

RECRUITING

Tampere University Hospital, Tampere

All Listed Sponsors
collaborator

Tampere University

OTHER

collaborator

Aalto University

OTHER

collaborator

University of Helsinki

OTHER

collaborator

University of Turku

OTHER

lead

Tampere University Hospital

OTHER